
Chemical giant Chemours delays quarterly earnings release, internal review underway
Citing ‘woke culture,’ Chemours director resigns over abortion benefits for employees
Stocks making the biggest moves in the premarket: Hibbett, Silvergate Capital, Chemours and more
Einhorn's Greenlight exited Chemours, Playboy and Warner Bros Discovery in Q3
3.27BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1638511089
CUSIP
163851108
Sector
Basic Materials
Industry
Specialty Chemicals
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
1.60
Book Value
1.43
Dividend Share
0.35
Dividend Yield
1.57%
Earnings Share
-2.73
Wall Street Target Price
25.78
EPS Estimate Current Year
1.30
EPS Estimate Next Year
2.27
EPS Estimate Current Quarter
-0.0404
EPS Estimate Next Quarter
0.6179
Most Recent Quarter
-
Revenue TTM
5,821,000,192
Gross Profit TTM
885,000,000
EBITDA
581,000,000
Profit Margin
-7.04%
Return On Assets TTM
2.13%
Return On Equity TTM
-103.01%
Revenue Per Share TTM
38.691
Qtly Revenue Growth YOY
1.00%
Diluted Eps TTM
-2.73
Qtly Earnings Growth YOY
-64.60%
Trailing PE
0.00
Forward PE
14
Price Sales TTM
0.53
Price Book MRQ
15.5763
Enterprise Value Revenue
1
Enterprise Value EBITDA
23
210.00
3.49%18.30
2.64%41.96
2.17%71.94
1.74%514.51
0.51%250.18
0.50%309.34
0.08%3373.75
0.00%175.20
0.00%290.19
-3.22%